Immune infiltration-based prognostic signature for molecular subtyping and therapeutic stratification in lung adenocarcinoma

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82203687)
  • National Natural Science Foundation of China (82472996)
  • National Natural Science Foundation of China (82573172)